Isabelle Carletti

Comparison of the immunogenicity and safety of<i>Cervarix</i>™ and<i>Gardasil</i>^®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years

Mark H. Einstein, Mira Baron, Myron J. Levin et al. · Human Vaccines · 2009 · 396 citations · Full text

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial

Geert Leroux‐Roels, Arnaud Marchant, Jack Lévy et al. · Clinical Immunology · 2016 · 108 citations · Full text

A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults

Stephen J. Thomas, Kenneth H. Eckels, Isabelle Carletti et al. · American Journal of Tropical Medicine and Hygiene · 2012 · 95 citations · Full text

Vaccination, Vaccine Safety, Immunogenicity Study +11

An Adjuvanted Polyprotein HIV-1 Vaccine Induces Polyfunctional Cross-Reactive CD4+ T Cell Responses in Seronegative Volunteers

Eva Van Braeckel, Patricia Bourguignon, Marguerite Koutsoukos et al. · Clinical Infectious Diseases · 2011 · 61 citations · Full text

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

Geert Leroux‐Roels, Pascale Van Belle, Pierre Vandepapelière et al. · Vaccine · 2014 · 48 citations · Full text